CRISPR Therapeutics AG (CRSP) News, Price and Chart

Mon April 26th, 2021

- 18:47
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisSkyworks Lifts Nasdaq Ahead of Earnings; CRISPR Keeps Moving ForwardThe Motley Fool
- 18:18
  AnalysisWhy Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving TodayBenzinga
- 12:48
  AnalysisCrispr Therapeutics: Strong Partnership And Data DevelopmentSeeking Alpha

Fri April 23rd, 2021

- 03:20
  AnalysisCrispr Therapeutics: Pipeline Catalyst Triggering UpsideSeeking Alpha

Wed April 21st, 2021

- 12:55
  AnalysisVertex (VRTX) Ups Investment in CRISPR Gene Therapy PartnershipZacks

Tue April 20th, 2021

- 20:29
  AnalysisVertex Pharmaceuticals Raises Bet on CRISPR TherapeuticsThe Motley Fool + 1 more
- 13:18
  AnalysisWhy Crispr, KalVista And Syndax Are Moving TodayBenzinga

Mon April 19th, 2021

- 19:39
  AnalysisCRISPR Therapeutics: A Speculative Play On The Future Of MedicineSeeking Alpha

Mon April 12th, 2021

- 17:14
  AnalysisCRISPR Therapeutics AG (CRSP) Presents at 20th Annual Needham Virtual Healthcare Conference (Transcript)Seeking Alpha

Tue April 6th, 2021

- 14:35
  AnalysisCRISPR Therapeutics's Leading Thalassemia And Sickle Cell Disease Investigational TherapySeeking Alpha

Fri April 2nd, 2021

- 11:27
  AnalysisARK Genomic Revolution Multi-Sector ETF: Poised For Continued UnderperformanceSeeking Alpha

Mon March 29th, 2021

- 12:04
  AnalysisVertex: An Undervalued Business With A Promising PipelineSeeking Alpha

Sun March 21st, 2021

- 18:41
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisTwist Bioscience: Growth Prospects And Commodity RiskSeeking Alpha

Wed March 17th, 2021

- 11:03
  AnalysisIs CRISPR Therapeutics Stock Poised to Soar Nearly 30%?The Motley Fool

Tue March 16th, 2021

- 13:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisVertex: 45% Upside RemainsSeeking Alpha

Mon March 15th, 2021

- 19:12
  AnalysisCRISPR Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents At 33rd Annual ROTH Conference (Transcript)Seeking Alpha

Sun March 14th, 2021

- 16:18
  Analysisbluebird bio's Awkward SilenceSeeking Alpha

Tue March 9th, 2021

- 19:35
  AnalysisCrispr Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents at Barclays Global Healthcare Conference 2017 (Transcript)Seeking Alpha
- 13:22
  AnalysisARK Innovation And The Demise Of Growth InvestingSeeking Alpha

Thu March 4th, 2021

- 20:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisIs CRISPR Stock Heading to $160 in 2021?The Motley Fool

Tue March 2nd, 2021

- 12:36
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisBetter Buy: CRISPR vs. Fulgent GeneticsThe Motley Fool
- 01:54
  AnalysisThe Buzzing Gene-Editing Market Of Crispr TherapeuticsSeeking Alpha

Mon March 1st, 2021

- 14:34
  AnalysisCrispr Therapeutics: Paving The Way For The Genomic Revolution, But Perhaps Too Early To Go All-InSeeking Alpha

Sun February 28th, 2021

- 21:02
  AnalysisARK Genomic Revolution Multi-Sector ETF: Proceed With CautionSeeking Alpha

Thu February 25th, 2021

- 18:01
  AnalysisThe Brave New Genomic WorldSeeking Alpha

Tue February 23rd, 2021

- 20:53
  AnalysisCRISPR Therapeutics: Roadblock AheadSeeking Alpha

Mon February 22nd, 2021

- 03:46
  AnalysisARK Fintech Innovation ETF: The Best ARK Fund To Buy And HoldSeeking Alpha

Wed February 17th, 2021

- 15:32
  EarningsAnalysisCRISPR Therapeutics (CRSP) Q4 Earnings Miss, Revenues Fall Y/YZacks

Tue February 16th, 2021

- 18:20
  AnalysisThe Must-Know, Nobel Prize-Winning Biotech Trend Of Gene Editas MedicineSeeking Alpha

Thu February 11th, 2021

- 14:01
  Press ReleasesAnalysisMeridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the DayZacks

Sat February 6th, 2021

- 09:23
  AnalysisThe Clough Closed-End Funds Continue To PerformSeeking Alpha

Fri February 5th, 2021

- 22:45
  AnalysisCRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should KnowZacks
- 14:32
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?Zacks

Wed February 3rd, 2021

- 17:30
  EarningsAnalysisAnalysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out forZacks

Tue February 2nd, 2021

- 20:13
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisInvesting In The 'New' Modern CorporationSeeking Alpha

Fri January 22nd, 2021

- 18:54
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  IPOAnalysisSana Biotechnology Seeks $150 Million U.S. IPOSeeking Alpha

Wed January 20th, 2021

- 13:23
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia TherapeuticsZacks

Tue January 19th, 2021

- 18:56
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisARKG: Potential Disruption For Healthcare And Pharma IndustriesSeeking Alpha
- 15:46
  AnalysisCRISPR (CRSP) Up More Than 80% in Past 3 Months: Here's WhyZacks

Mon January 11th, 2021

- 13:02
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex PharmaceuticalsZacks